Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1529 of 5804
-
Blood and stool tests could revolutionize IBD monitoring
Knowledge-focused Recruiting nowThe goal of this observational study is to establish a multicenter prospective clinical and biospecimen platform for biomarker discovery and validation in inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Researchers want to learn whether candidate bi…
Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
AI outperforms some doctors in spotting thyroid cancer on ultrasound
Diagnosis CompletedThe aim of this study was to evaluate the performance of artificial intelligence (AI) technology in the diagnosis of thyroid nodules, specifically in the field of ultrasound image analysis. It focuses on the accuracy and clinical feasibility of the AI system based on the Vision-L…
Sponsor: Ma Zhe • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
New Clot-Busting device could save stroke patients
Disease control Recruiting nowThe primary aim of Registrap study is to assess the safety and effectiveness of the EmboTrap®II Clot Retriever device (Neuravi) in patients with acute ischemic stroke from large vessel occlusion.
Sponsor: Niguarda Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Blood test could spot neuroblastoma relapse early
Knowledge-focused Recruiting nowThis prospective observational study evaluates serial circulating tumor DNA (ctDNA) and molecular residual disease (MRD) monitoring in patients with neuroblastoma. The study aims to characterize baseline genomic alterations, assess ctDNA detectability and dynamic changes during t…
Sponsor: Sun Yat-sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Heart attack patients under 60 get genetic screening for hidden cholesterol disorder
Diagnosis CompletedACCURATE will test the hypothesis that opportunistic genetic testing for Familial Hypercholesterolemia (FH) in patients admitted to hospital with an acute coronary syndrome will increase the diagnosis of FH and will impact patient care and outcomes. The study will recruit patient…
Phase: NA • Sponsor: University of British Columbia • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
Could an arthritis drug help rare lung disease patients?
Disease control CompletedRefractory anti-synthetase syndrome-associated interstitial lung disease (ASyS-ILD) lacks targeted therapy. Interleukin-6 drives both inflammation and fibrosis. We evaluated the real-world efficacy and safety of tocilizumab, an IL-6 receptor antagonist. This single-center retros…
Sponsor: Hu Yinan • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New stent technique aims to tame deadly aortic aneurysms without open surgery
Disease control Recruiting nowMulti-Branch AOrtic Reconstruction With G-iliac System (BAO-G) Technique is a novel technique of endovascular repair of complex aortic aneurysm, which using off-the-shelf iliac branched devices to reconstruct the visceral branches. This study aims to verify the perioperative safe…
Phase: PHASE1 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 26, 2026 13:52 UTC
-
Small incision during heart surgery may prevent dangerous Post-Op heart rhythm problem
Prevention CompletedA single-center, randomized controlled trial in Yemen evaluating whether posterior pericardiotomy (PP) reduces postoperative atrial fibrillation (POAF) after open-heart surgery. 210 patients undergoing CABG, aortic valve replacement, ascending aortic surgery, or combined procedur…
Phase: NA • Sponsor: Taiz University - Faculty of Medicine • Aim: Prevention
Last updated Jun 27, 2026 08:02 UTC
-
New radiation method aims to improve sarcoma surgery outcomes
Disease control Recruiting nowTo investigate the feasibility and peri-operative complications of preoperative hypo-fractionated radiotherapy followed by surgery for retroperitoneal sarcoma
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could magnetic pulses to the brain ease IBS pain?
Symptom relief ENROLLING_BY_INVITATIONThe goal of this clinical trial is to explore if "individualized repetitive Transcranial Magnetic Stimulation (TMS)" works to improve symptoms in adults with Irritable Bowel Syndrome (IBS). It also aims to learn how this treatment works (by looking at links between the brain, gut…
Phase: NA • Sponsor: The Affiliated Hospital of Hangzhou Normal University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Stent showdown: double stents may clear tough bile stones in cirrhosis patients
Disease control CompletedThis prospective, single-center, interventional study enrolled 400 cirrhotic patients with large or complex common bile duct (CBD) stones that could not be removed during an initial Endoscopic Retrograde Cholangiopancreatography (ERCP). The study compared four different plastic b…
Phase: NA • Sponsor: National Liver Institute, Egypt • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Personalized dosing of Immune-Suppressing drug may improve stem cell transplant outcomes
Disease control CompletedThe purpose of this study is to determine the response and toxicity rate of two different dosages (Individualized dosage VS. fixed dosage) of ATG as a prophylaxis for acute GVHD in haploidentical peripheral blood stem cell transplantation (haplo-PBSCT).
Phase: PHASE3 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Real-world study confirms mepolizumab cuts asthma attacks and steroid use
Disease control CompletedThis study is aimed at evaluation of the efficacy of mepolizumab 100 mg subcutaneously (SC) every 4 weeks in patients with severe eosinophilic asthma who have been treated for at least 12 months in several Polish allergy/asthma centres under the same protocol. Target population t…
Sponsor: Medical University of Lodz • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Vitamin B12 shows promise in preventing chemo side effect
Prevention OngoingA multicenter, randomized, placebo-controlled, double-blind, phase III clinical trial will be conducted to explore the efficacy and safety of mecobalamin in the prevention of 2/3 HFS in patients with early breast cancer. 234 patients will be enrolled and will be randomized into m…
Phase: PHASE3 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Prevention
Last updated Jun 27, 2026 09:01 UTC
-
New program aims to boost lung cancer screening in tribal communities
Knowledge-focused OngoingLung cancer is the leading cause of cancer mortality among American Indians and Alaska Natives (AI/AN), and AI/AN have worse lung cancer incidence rates, survival, and death compared to the general population. Because lung cancer screening (LCS) with low-dose computed tomography …
Phase: NA • Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
New eye injection shows promise for Diabetes-Related vision loss
Disease control CompletedStudy BP43445 is a phase II, multicenter, randomized, double-masked, active comparator-controlled study to investigate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of vamikibart administered intravitreally in participants with diabetic macular edema.…
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New antibody HX009 shows promise for tough lymphoma cases
Disease control CompletedThis study is a multi-center, open, single-arm phase I/II clinical study to evaluate the recombinant humanized anti-CD47/PD-1 bifunctional antibody HX009 injection in Chinese patients with relapsed/refractory lymphoma .
Phase: PHASE1, PHASE2 • Sponsor: Hangzhou Hanx Biopharmaceuticals, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Myeloma patients may soon ditch daily pills if cancer stays hidden
Disease control Recruiting nowA pilot study to assess the risk of progression after stopping post-autologous stem cell transplant (ASCT) maintenance therapy in Minimal Residual Disease (MRD)-negative MM patients.
Phase: PHASE1 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New drug aims to cut Blood-Letting in rare blood cancer
Disease control CompletedThe main purpose of this study is to evaluate the efficacy of sapablursen in reducing the frequency of phlebotomy and in improving quality of life assessments in participants with polycythemia vera.
Phase: PHASE2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New drug shows promise for Hard-to-Treat lung condition in heart failure
Disease control CompletedThis is a Phase 2, double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of sotatercept versus placebo in adults with Cpc-PH due to HFpEF. The objective of this study is to evaluate the efficacy, safety and tolerability of sotatercept versus plac…
Phase: PHASE2 • Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC